ArticleBiological trace element research2026
Bioaccessibility and Health Risk Assessment of Arsenic in Realgar-Containing Traditional Chinese Medicines.
Jianchao Li, Nuo Deng, Fei Wang, Huilin Zhu, Yongming Li, Xiao Wu
Abstract read
In one paragraphArticle in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Jianchao LiSchool of Medicine, Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Nuo DengSchool of Medicine, Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Fei WangSchool of Medicine, Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Huilin ZhuSchool of Medicine, Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Nanjing University of Chinese Medicine, Nanjing, 210023, China.
Yongming LiSchool of Medicine, Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Nanjing University of Chinese Medicine, Nanjing, 210023, China. lym-569@njucm.edu.cn.
Xiao WuSchool of Medicine, Jiangsu Provincial Key Laboratory of Functional Substances in Traditional Chinese Medicine Formulae and Innovative Drug Discovery, Nanjing University of Chinese Medicine, Nanjing, 210023, China. xwu@njucm.edu.cn.
Funding
National Natural Science Foundation of China 82104523Natural Science Foundation of Jiangsu Province BK20200843Natural Science Foundation of Jiangsu Province BK20211296
6 · The paper itselfAbstract
As a traditional Chinese medicine (TCM) composed of As
Indexed as
ArsenicArsenicalsDrugs, Chinese HerbalMedicine, Chinese TraditionalSulfidesHumansRisk AssessmentSpectrometry, FluorescenceArsenicArsenicalsarsenic disulfideDrugs, Chinese HerbalSulfidesArsenicBioaccessibilityHealth risk assessmentHydride generation–atomic fluorescence spectrometryRealgarTraditional Chinese medicines
What OpenQuestion holds
Textmetadata
Read underepoch 390